(Q35152268)

6 August 2017

title

The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001. (English)

1 reference

6 August 2017

1 reference

2

M Christopher Auld

1 reference

6 August 2017

Hartmut B Krentz

1

1 reference

6 August 2017

M John Gill

series ordinal

3

1 reference

6 August 2017

HIV Economic Study Group

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Canadian Medical Association Journal

6 August 2017

published in

1 reference

6 August 2017

volume

169

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

106-110

1 reference

Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

Health economics in HIV disease. A review of the European literature

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

Direct costs of health care for HIV/AIDS patients in Belgium.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

The impact of new antiretroic therapeutic schemes on the cost for AIDS treatment in Greece.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

The changing economics of HIV care.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

Average annual drug cost and its determinants in a population based cohort of HIV-positive adult men and women

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164974

Long-term impact of highly active antiretroviral therapy on HIV-related health care costs

27 September 2018

1 reference

12 December 2020

Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infection

1 reference

12 December 2020

[Cost of HIV treatment in highly active antiretroviral therapy in Japan]

1 reference

12 December 2020

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Identifiers

PMC publication ID

164974

1 reference

6 August 2017

1 reference